Product Code: ETC13399790 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Apheresis Market was valued at USD 2.8 Billion in 2024 and is expected to reach USD 4.7 Billion by 2031, growing at a compound annual growth rate of 4.80% during the forecast period (2025-2031).
The Global Apheresis Market is experiencing steady growth driven by factors such as increasing prevalence of chronic diseases, rising demand for blood components and plasma-derived products, technological advancements in apheresis procedures, and growing adoption of therapeutic apheresis in various medical conditions. The market is segmented based on product type (disposables, devices), procedure type (therapeutic apheresis, photopheresis, donor apheresis), application (renal diseases, neurological disorders, hematology), and end-user (hospitals, blood donation centers, clinics). North America holds a significant market share due to a well-established healthcare infrastructure and high adoption rates of advanced medical technologies. However, the Asia-Pacific region is poised for rapid growth due to increasing healthcare expenditure, improving healthcare infrastructure, and rising awareness about apheresis procedures. Key players in the global apheresis market include Terumo BCT, Fresenius SE & Co. KGaA, Haemonetics Corporation, and Baxter International Inc.
The Global Apheresis Market is seeing a growing demand due to the rising prevalence of chronic diseases such as cancer, autoimmune disorders, and blood disorders. Technological advancements in apheresis equipment, such as the development of automated systems for improved efficiency and safety, are driving market growth. Additionally, the increasing awareness about apheresis therapies and their benefits among healthcare professionals and patients is contributing to market expansion. Opportunities lie in the expansion of apheresis applications beyond traditional uses to include emerging areas such as regenerative medicine and cell therapy. The market is also witnessing collaborations between key players and research institutions to innovate new therapies and enhance existing apheresis techniques, further fueling market growth.
The Global Apheresis Market faces several challenges, including high costs associated with apheresis procedures, limited reimbursement policies, and the need for specialized equipment and trained personnel. Additionally, there is a shortage of donors for apheresis procedures, which can hinder the availability of blood components for therapeutic purposes. Moreover, regulatory hurdles and stringent approval processes for apheresis devices and technologies pose challenges for market growth. Competition from alternative therapies and the lack of awareness about apheresis among healthcare providers and patients also impact market expansion. Overall, addressing these challenges will be crucial for the sustained growth and development of the Global Apheresis Market.
The Global Apheresis Market is primarily driven by the increasing prevalence of chronic diseases such as cancer, autoimmune disorders, and blood-related disorders, which require apheresis procedures for treatment. Technological advancements in apheresis devices and procedures have improved efficiency and safety, further boosting market growth. The rising demand for blood components and plasma for therapeutic purposes, along with the growing number of organ transplant procedures, also contribute to the market expansion. Additionally, the increasing geriatric population worldwide, who are more susceptible to various chronic conditions, drives the demand for apheresis procedures. Moreover, the expanding application of apheresis in treating rare diseases and neurological disorders is expected to fuel market growth in the coming years.
Government policies related to the Global Apheresis Market vary by country but generally focus on regulating the safety, efficacy, and quality of apheresis procedures and devices. In the United States, the Food and Drug Administration (FDA) oversees the approval and monitoring of apheresis equipment and processes to ensure patient safety and treatment effectiveness. Additionally, reimbursement policies set by government healthcare programs such as Medicare and Medicaid can impact the accessibility and affordability of apheresis treatments for patients. In Europe, regulatory bodies like the European Medicines Agency (EMA) and national health authorities provide oversight and guidance on apheresis practices. Overall, government policies play a crucial role in shaping the regulatory framework and reimbursement landscape for the Global Apheresis Market, influencing market dynamics and patient access to these essential therapies.
The Global Apheresis Market is expected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of chronic diseases, rising demand for blood components, technological advancements in apheresis procedures, and growing awareness about the benefits of apheresis therapy. The market is also likely to be propelled by the expanding applications of apheresis in various therapeutic areas such as neurology, hematology, oncology, and autoimmune diseases. Additionally, the rising healthcare expenditure in emerging economies, improving healthcare infrastructure, and the growing aging population are anticipated to further boost market growth. However, challenges such as high costs associated with apheresis procedures, lack of skilled professionals, and stringent regulatory requirements may hinder market expansion to some extent. Overall, the Global Apheresis Market is poised for robust growth in the foreseeable future.
In the global apheresis market, North America holds the largest market share, driven by the presence of key market players, high healthcare spending, and advanced healthcare infrastructure. Asia Pacific is expected to witness significant growth due to the increasing prevalence of chronic diseases, improving healthcare facilities, and rising awareness about apheresis procedures. Europe is also a key market, supported by the presence of a large patient pool, favorable government initiatives, and technological advancements in apheresis products. The Middle East and Africa region is experiencing steady growth, attributed to the rising incidence of blood disorders and increasing healthcare investments. Latin America is also emerging as a promising market, fueled by improving healthcare infrastructure, growing medical tourism, and rising adoption of apheresis techniques for various therapeutic applications.
Global Apheresis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Apheresis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Apheresis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Apheresis Market - Industry Life Cycle |
3.4 Global Apheresis Market - Porter's Five Forces |
3.5 Global Apheresis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Apheresis Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Apheresis Market Revenues & Volume Share, By Method, 2021 & 2031F |
3.8 Global Apheresis Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.9 Global Apheresis Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.10 Global Apheresis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Apheresis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Apheresis Market Trends |
6 Global Apheresis Market, 2021 - 2031 |
6.1 Global Apheresis Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Apheresis Market, Revenues & Volume, By Devices, 2021 - 2031 |
6.1.3 Global Apheresis Market, Revenues & Volume, By Disposable and Reagents, 2021 - 2031 |
6.1.4 Global Apheresis Market, Revenues & Volume, By Software, 2021 - 2031 |
6.2 Global Apheresis Market, Revenues & Volume, By Method, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Apheresis Market, Revenues & Volume, By Centrifugation, 2021 - 2031 |
6.2.3 Global Apheresis Market, Revenues & Volume, By Membrane Separation, 2021 - 2031 |
6.2.4 Global Apheresis Market, Revenues & Volume, By Selective Adsorption, 2021 - 2031 |
6.3 Global Apheresis Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Apheresis Market, Revenues & Volume, By Donor/Automated Apheresis, 2021 - 2031 |
6.3.3 Global Apheresis Market, Revenues & Volume, By Therapeutic Apheresis, 2021 - 2031 |
6.4 Global Apheresis Market, Revenues & Volume, By Component, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Apheresis Market, Revenues & Volume, By Plasma (Plasmapheresis), 2021 - 2031 |
6.4.3 Global Apheresis Market, Revenues & Volume, By Platelets (Plateletpheresis), 2021 - 2031 |
6.4.4 Global Apheresis Market, Revenues & Volume, By Leukocytes (Leukapheresis or leukopheresis), 2021 - 2031 |
6.4.5 Global Apheresis Market, Revenues & Volume, By Lymphocytes (Lymphopheresis or lymphapheresis), 2021 - 2031 |
6.4.6 Global Apheresis Market, Revenues & Volume, By RBC's (Erythropheresis), 2021 - 2031 |
6.5 Global Apheresis Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Apheresis Market, Revenues & Volume, By Blood Centers, 2021 - 2031 |
6.5.3 Global Apheresis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.4 Global Apheresis Market, Revenues & Volume, By Other End Users, 2021 - 2031 |
7 North America Apheresis Market, Overview & Analysis |
7.1 North America Apheresis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Apheresis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Apheresis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Apheresis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Apheresis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Apheresis Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Apheresis Market, Revenues & Volume, By Method, 2021 - 2031 |
7.5 North America Apheresis Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.6 North America Apheresis Market, Revenues & Volume, By Component, 2021 - 2031 |
7.7 North America Apheresis Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Apheresis Market, Overview & Analysis |
8.1 Latin America (LATAM) Apheresis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Apheresis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Apheresis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Apheresis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Apheresis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Apheresis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Apheresis Market, Revenues & Volume, By Product, 2021 - 2031 |
8.4 Latin America (LATAM) Apheresis Market, Revenues & Volume, By Method, 2021 - 2031 |
8.5 Latin America (LATAM) Apheresis Market, Revenues & Volume, By Procedure, 2021 - 2031 |
8.6 Latin America (LATAM) Apheresis Market, Revenues & Volume, By Component, 2021 - 2031 |
8.7 Latin America (LATAM) Apheresis Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Apheresis Market, Overview & Analysis |
9.1 Asia Apheresis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Apheresis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Apheresis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Apheresis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Apheresis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Apheresis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Apheresis Market, Revenues & Volume, By Product, 2021 - 2031 |
9.4 Asia Apheresis Market, Revenues & Volume, By Method, 2021 - 2031 |
9.5 Asia Apheresis Market, Revenues & Volume, By Procedure, 2021 - 2031 |
9.6 Asia Apheresis Market, Revenues & Volume, By Component, 2021 - 2031 |
9.7 Asia Apheresis Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Apheresis Market, Overview & Analysis |
10.1 Africa Apheresis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Apheresis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Apheresis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Apheresis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Apheresis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Apheresis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Apheresis Market, Revenues & Volume, By Product, 2021 - 2031 |
10.4 Africa Apheresis Market, Revenues & Volume, By Method, 2021 - 2031 |
10.5 Africa Apheresis Market, Revenues & Volume, By Procedure, 2021 - 2031 |
10.6 Africa Apheresis Market, Revenues & Volume, By Component, 2021 - 2031 |
10.7 Africa Apheresis Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Apheresis Market, Overview & Analysis |
11.1 Europe Apheresis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Apheresis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Apheresis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Apheresis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Apheresis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Apheresis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Apheresis Market, Revenues & Volume, By Product, 2021 - 2031 |
11.4 Europe Apheresis Market, Revenues & Volume, By Method, 2021 - 2031 |
11.5 Europe Apheresis Market, Revenues & Volume, By Procedure, 2021 - 2031 |
11.6 Europe Apheresis Market, Revenues & Volume, By Component, 2021 - 2031 |
11.7 Europe Apheresis Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Apheresis Market, Overview & Analysis |
12.1 Middle East Apheresis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Apheresis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Apheresis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Apheresis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Apheresis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Apheresis Market, Revenues & Volume, By Product, 2021 - 2031 |
12.4 Middle East Apheresis Market, Revenues & Volume, By Method, 2021 - 2031 |
12.5 Middle East Apheresis Market, Revenues & Volume, By Procedure, 2021 - 2031 |
12.6 Middle East Apheresis Market, Revenues & Volume, By Component, 2021 - 2031 |
12.7 Middle East Apheresis Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Apheresis Market Key Performance Indicators |
14 Global Apheresis Market - Export/Import By Countries Assessment |
15 Global Apheresis Market - Opportunity Assessment |
15.1 Global Apheresis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Apheresis Market Opportunity Assessment, By Product, 2021 & 2031F |
15.3 Global Apheresis Market Opportunity Assessment, By Method, 2021 & 2031F |
15.4 Global Apheresis Market Opportunity Assessment, By Procedure, 2021 & 2031F |
15.5 Global Apheresis Market Opportunity Assessment, By Component, 2021 & 2031F |
15.6 Global Apheresis Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Apheresis Market - Competitive Landscape |
16.1 Global Apheresis Market Revenue Share, By Companies, 2024 |
16.2 Global Apheresis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |